Ventas, Inc. is a real estate investment trust (REIT) that owns and operates a portfolio of senior housing communities, outpatient medical buildings, research centers, hospitals, and healthcare facilities in North America and the United Kingdom. The company operates through three reportable segments: the senior housing operating portfolio (SHOP), the outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). Its senior housing assets include independent living, assisted living, memory care, and continuing care retirement communities, often managed by third-party operators. Ventas also maintains a third-party institutional private capital management platform called Ventas Investment Management (VIM), which partners with institutional investors in real estate joint ventures, including the Ventas Life Science & Healthcare Real Estate Fund. The company holds investments in operating entities such as Ardent Health, Inc. and Atria Senior Living, Inc. It utilizes a proprietary data and analytics platform named Ventas OI to support operational decision-making, marketing analytics, and investment strategies. Ventas serves an aging population by providing residential and medical environments, with a focus on capturing demographic demand in the longevity economy.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry REIT - Healthcare Facilities Homepage ventasreit.com
Sector Real Estate IR page ir.ventasreit.com/overview/default.aspx
Tags
senior housing, assisted living, memory care, outpatient medical, research centers, triple-net lease, private capital management, longevity economy, healthcare real estate, continuing care, Ventas OI, Ventas Investment Management, Ventas Life Science & Healthcare Real Estate Fund, Ardent Health Inc., Atria Senior Living Inc., Avanti Senior Living at Flower Mound, The Branches of Framingham, St. Francis Millennium Medical Building, Country Club at La Cholla
Press page —

Metrics

Valuation  
Market cap $ 44.96B
Market cap (USD) $ 44.96B
P/E 154.58
PEG —
P/BV 2.84
P/S 6.63
P/OCF 23.51
P/FCF -35.09
Dividend yield 2.3%
Turnover / mcap —
Returns  
ROE 2.2%
ROI 1.0%
ROIC 3.4%
Profit margin 4.5%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 103.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 13
Quality score 15.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 5.834B 4.924B 4.498B 4.129B 3.828B 3.795B 3.873B 3.746B 3.574B 3.444B 3.286B 3.076B 2.81B 2.485B 1.765B 1.009B 936.094M 929.766M 771.791M 428.349M 332.988M 236.856M 205.003M 196.704M 204.581M —
Net profit 261.518M 88.351M -30.297M -40.931M 56.559M 441.185M 439.297M 415.981M 1.361B 651.49M 419.222M 477.186M 454.889M 361.775M 363.261M 249.729M 266.495M 226.288M 282.318M 131.43M 130.583M 120.9M 162.753M 65.706M 50.566M —
Free cash flow -1.281B -1.2B 470.402M 219.467M -775.905M 842.88M 1.281B 1.25B 1.31B 1.25B 1.284B 1.167B 1.113B 923.386M 722.724M 429.429M 408.303M 347.816M 393.438M — — 149.756M 137.108M 116.077M 78.776M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 77.38 58.89 49.84 45.05 51.12 49.04 57.74 58.59 60.01 62.52 56.43 71.7 57.28 64.72 55.5 52.52 43.74 33.54 46.15 42.05 — — — — — —
Price performance 12m 0.31 0.18 0.11 -0.12 0.04 -0.15 -0.01 -0.02 -0.04 0.11 -0.21 0.25 -0.11 0.17 0.06 0.2 0.3 -0.27 0.1 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — — — — — — 76.1M 108M 99.9M
↳ YoY growth +42.1% -7.6%
Borrowings, current (USD) — — 0.00 568M 0.00 280M 403M 0.00 0.00 0.00
Lease liabilities (USD) — — 0.00 251M 210M 197M 190M 195M 218M 209M
Cash and deposits (USD) 287M 81.4M 72.3M 106M 413M 150M 123M 509M 898M 741M
Right-of-use assets (USD) — — 0.00 385M 346M 318M 310M 312M 308M 296M
Net debt (borrowings + leases - cash) (USD) — — -72.3M 712M -203M 328M 471M -314M -680M -532M
Cash flow detail
Operating cash flow (USD) 1.37B 1.44B 1.38B 1.44B 1.45B 1.03B 1.12B 1.12B 1.33B 1.65B
Purchases of property, plant and equipment (USD) -117M -133M -132M -157M -607M -1.8B -901M -649M -2.53B -2.93B
Change in payables (cash effect) (USD) -43.6M -35.3M -37.5M 26.7M 190M 16.7M 7.2M -6.41M 134M 81M
Dividends paid (cash effect) (USD) -1.02B -827M -1.13B -1.16B -929M -687M -720M -724M -740M -860M
Interest paid (cash effect) (USD) -395M -410M -407M -411M -430M -402M -468M -548M -576M -580M
Income taxes paid (cash effect) (USD) — — — — — — — — -3.04M -7.31M
Share-based compensation (USD) 21M 26.5M 30M 33.9M 21.5M 32M 30.7M 31M 31M 38.7M
Free cash flow (OCF - PPE - intangibles) (USD) 1.25B 1.31B 1.25B 1.28B 843M -776M 219M 470M -1.2B -1.28B
Income detail
Total comprehensive income (USD) 602M 1.38B 432M 426M 423M 49.3M -15.2M -28.3M 82.3M 257M
Comprehensive income to owners (USD) 599M 1.38B 425M 418M 419M 38.8M -19.7M -39.9M 83.4M 245M
Reported Feb 14, 2017 Feb 9, 2018 Apr 29, 2019 Feb 24, 2020 Feb 23, 2021 Feb 18, 2022 Feb 10, 2023 Feb 13, 2025 Feb 6, 2026 Feb 6, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Ventas, Inc. — Other Events Bull 1 Bear 1 Financing

On November 10, 2026, Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of Ventas, Inc. (the “Company”), issued and sold $500,000,000 in aggregate principal amount of its 5.500% Senior Notes due 2033 (the “Notes”) in a registered public offering pursuant to the existing registration statement of the Company and Ventas Realty on Form S-3 (File Nos. 333-277185 and 333-277185-01) filed under the Securities Act of 1933, as amended. The Notes are guaranteed by the Company on a senior unsecured basis. The Company intends to use the proceeds from this offering for general corporate purposes, which may include repayment of other indebtedness, or any other general corporate purposes the Company may deem necessary or advisable, and to pay related fees and expenses.

The Notes were sold pursuant to an underwriting agreement, dated November 5, 2026 (the “Underwriting Agreement”), among Ventas Realty, the Company and the underwriters named therein.

Ventas Announces Pricing of Senior Notes Offering Bull 0 Bear 0 Financing

11/05/2026

CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership (“Ventas Realty”), has priced an underwritten public offering of $500.0 million aggregate principal amount of 5.500% Senior Notes due 2033 (the “Notes”) at an issue price equal to 99.441% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guaranteed by the Company and will mature on December 15, 2033. The sale of the Notes is expected to close on November 10, 2026, subject to the satisfaction of customary closing conditions.

The Company intends to use the proceeds from the offering of the Notes for general corporate purposes, which may include repayment of other indebtedness, or any other general corporate purposes the Company may deem necessary or advisable, and to pay fees and expenses related to the offering of the Notes.

J.P. Morgan Securities LLC, BofA Securities, Inc., Citigroup Global Markets Inc., PNC Capital Markets LLC and SMBC Nikko Securities America, Inc. are acting as joint book-running managers for the offering of the Notes.

The Company and Ventas Realty have filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the Securities and Exchange Commission (the “SEC”) for the offering of the Notes to which this communication relates. Before you invest, you should read the preliminary prospectus supplement, the accompanying prospectus in that registration statement and the other documents the Company and Ventas Realty have filed with the SEC for more complete information about the Company, Ventas Realty and this offering. You may get these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, the Company, Ventas Realty, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement and the accompanying prospectus if you request it by contacting: J.P. Morgan Securities LLC collect at 1-212-834-4533; BofA Securities, Inc. toll-free at 1-800-294-1322; Citigroup Global Markets Inc. toll-free at 1-800-831-9146 or email:[email protected]; PNC Capital Markets LLC toll-free at 1-855-881-0697; and SMBC Nikko Securities America, Inc. toll-free at 1-888-868-6856.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

About Ventas

Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,500 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its approximately 1,000 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements regarding the expected closing of the offering of the Notes and the anticipated use of the proceeds therefrom, and statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of phrases or words such as “assume,” “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “target,” “forecast,” “plan,” “line-of-sight,” “outlook,” “potential,” “opportunity,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management’s beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled “Cautionary Statements — Summary Risk Factors” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K as we file them with the Securities and Exchange Commission.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, artificial intelligence, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers’, tenants’ and borrowers’ business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic and general economic conditions on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, and the actual and perceived state of the real estate markets and public and private capital markets; (c) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (d) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (e) our ability to identify and consummate future investments in healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (f) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (g) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or lease from, us, which limits our control and influence over such properties, their operations and their performance; (h) our reliance and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (i) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants, borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us; (j) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (k) our exposure to various operational risks, liabilities and claims from our operating assets; (l) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (m) our ownership of properties or operation of business outside of the U.S. that may subject us to different or greater risks than those associated with our domestic operations; (n) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (o) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (p) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets; (q) the risk of exposure to unknown liabilities from our investments in properties or businesses; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (s) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (t) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries’ existing indebtedness; (u) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (v) the risk of potential dilution resulting from future sales or issuances of our equity securities; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risks or uncertainties relating to the use of, or inability to take advantage of, the benefits of artificial intelligence by us or our managers, tenants or borrowers; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers’, tenants’ or borrower’s operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the risk of catastrophic or extreme weather and other natural events; (aa) our ability to attract and retain talented employees; (bb) our ability to maintain a positive reputation for quality and service with our key stakeholders; (cc) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (dd) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (ee) risks and uncertainties related to the UPREIT Reorganization; and (ff) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

BJ Grant (877) 4-VENTAS

Source: Ventas, Inc.

View All News

Contact: BJ Grant

(877) 4-VENTAS

Ventas Reports 2026 Third Quarter Results

CHICAGO – Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2026.

CEO Remarks

“Ventas delivered strong enterprise results and growth in the third quarter, as we executed our 1-2-3 strategy and drove outperformance at scale. Our large and growing Senior Housing Operating Portfolio (“SHOP”) powered the Company’s organic property growth, and we used our differentiated platform, operating expertise and data advantages to generate results that significantly outperformed industry benchmarks,” said Debra A. Cafaro, Ventas Chairman and CEO.

“Additionally, we are aggressively expanding our SHOP business through attractive acquisitions designed to increase our enterprise growth and enhance the Company’s multiyear growth outlook. We have closed over $5 billion of investments focused on U.S. senior housing year to date. We have significant momentum in the market, and we are currently advancing our robust pipeline of actionable SHOP investment opportunities.

Prompts

Ventas, Inc. (ticker VTR), listed in United States.

Company History

Date Change Detail
Mar 30, 2012 Acquired Acquired Cogdell Spencer Inc. (CIK 1332896). Its filings from before the deal are on its own company page, not shown here.
May 5, 2011 Acquired Acquired Nationwide Health Properties Inc (CIK 780053). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Ventas, Inc.

ETF Weight in ETF Shares Market value As of
HAUS 5.64% 4,820 $ 427.775K Nov 9, 2026
JPRE 4.93% 265,026 $ 23.333M Nov 17, 2026
JRE 4.64% 2,085 $ 194.968K Jul 31, 2026
BYRE 4.48% 12,908 $ 1.146M Jun 30, 2026
VGSR 4.20% 247,437 $ 21.972M Jun 30, 2026
DFAR 3.56% 3,424,747 $ 307.029M Nov 12, 2026
GARA 3.28% 152 $ 13.498K Jun 30, 2026
FPRO 3.15% 5,567 $ 520.57K Jul 31, 2026
IYRI 3.13% 109,684 $ 9.325M Sep 30, 2026
AVRE 2.55% 256,418 $ 22.79M Nov 16, 2026
DFGR 2.33% 1,041,337 $ 93.356M Nov 12, 2026
SAMT 2.21% 218,342 $ 19.389M Jun 30, 2026
JDIV 1.56% 2,181 $ 192.015K Nov 17, 2026
JGLO 1.42% 931,949 $ 82.049M Nov 17, 2026
DPRE 1.32% 562 $ 52.553K Jul 31, 2026
UPSD 1.12% 13,969 $ 1.306M Jul 31, 2026
LCAP 1.02% 209,198 $ 18.577M Jun 30, 2026
FMAG 0.95% 25,099 $ 2.347M Jul 31, 2026
FFSM 0.89% 143,184 $ 13.389M Jul 31, 2026
LVDS 0.84% 11,345 $ 998.814K Nov 17, 2026
FMDE 0.81% 677,326 $ 60.147M Jun 30, 2026
CAPE 0.78% 21,054 $ 1.87M Jun 30, 2026
MCDS 0.77% 687 $ 60.483K Nov 17, 2026
FREI 0.76% 360,016 $ 33.665M Jul 31, 2026
VFMV 0.63% 31,064 $ 2.832M Aug 31, 2026
WCEO 0.61% 655 $ 61.249K Jul 31, 2026
FEMV 0.58% 344 $ 30.547K Jun 30, 2026
JEPI 0.56% 2,931,380 $ 258.079M Nov 17, 2026
JAVA 0.55% 462,600 $ 40.727M Nov 17, 2026
HELO 0.51% 273,806 $ 24.106M Nov 17, 2026
FFLC 0.46% 59,730 $ 5.585M Jul 31, 2026
LCDS 0.45% 820 $ 72.193K Nov 17, 2026
JOYT 0.44% 5,921 $ 521.285K Nov 17, 2026
BTAL 0.41% 13,156 $ 1.168M Jun 30, 2026
RAAX 0.37% 57,976 $ 4.929M Sep 30, 2026
JUSA 0.36% 35,355 $ 3.113M Nov 17, 2026
ENHU 0.34% 357 $ 31.73K Nov 16, 2026
FYEE 0.28% 6,500 $ 607.815K Jul 31, 2026
TVAL 0.28% 35,514 $ 3.156M Nov 17, 2026
FELV 0.21% 74,187 $ 6.588M Jun 30, 2026
BDVL 0.17% 34,682 $ 3.083M Nov 16, 2026
JFLI 0.17% 902 $ 79.412K Nov 17, 2026
NBCR 0.17% 15,682 $ 1.43M Aug 31, 2026
TACU 0.16% 335 $ 29.775K Nov 17, 2026
FTLS 0.15% 43,226 $ 0.00 Nov 16, 2026
FFLV 0.13% 229 $ 21.414K Jul 31, 2026
HBTA 0.13% 3,444 $ 313.989K Aug 31, 2026
RAA 0.12% 8,014 $ 711.643K Jun 30, 2026
XMAG 0.10% 2,519 $ 225.828K Nov 13, 2026
IALT 0.09% 81,664 $ 7.258M Nov 16, 2026
GSPY 0.07% 5,449 $ 484.307K Nov 17, 2026
AAUS 0.07% 4,136 $ 360K Nov 18, 2026
VOXP 0.06% 39 $ 3,646.89 Jul 31, 2026
HCMT 0.06% 3,382 $ 316.251K Jul 31, 2026
APUE 0.05% 14,240 $ 1.298M Aug 31, 2026
NTSD 0.05% 204 $ 18.115K Jun 30, 2026
LGDX 0.05% 783 $ 69.593K Nov 17, 2026
NTSX 0.05% 7,345 $ 652.236K Jun 30, 2026
GDE 0.04% 2,311 $ 210.694K Aug 31, 2026
THEQ 0.04% 176 $ 15.643K Nov 17, 2026
ACVF 0.04% 675 $ 63.119K Jul 31, 2026
CGHY 0.04% 689 $ 61.238K Nov 16, 2026
CSHP 0.02% 1,033 $ 91.813K Nov 16, 2026
FELC 0.00% 64 $ 5,683.20 Jun 30, 2026
CORO 0.00% 324 $ 28.753K Nov 16, 2026